Sign in

Alex Ralph

@alexralph.bsky.social
30 followers 10 following 4 posts

Chief Business Correspondent @thetimes.com

PostsRepliesMedia
Alex Ralph @alexralph.bsky.social · 22/01/2025
Interview with new Make UK chairman Lord Harrington on the industrial strategy, FDI and growth The veteran businessman and politician will have an important role shaping UK industry half a century after watching its decline growing up in Leeds www.thetimes.com/business-mon...
thetimes.com
Make UK’s next chair: ‘Look to our rivals for an industrial strategy’
In the 1960s his father’s shirt factory succumbed to cheaper overseas labour. Now Richard Harrington has a key role in boosting Britain’s manufacturing base
000
Alex Ralph @alexralph.bsky.social · 20/01/2025
Delays in securing government support have led AstraZeneca to miss a key internal deadline on a proposed £450 million investment in a new vaccines facility in Speke, despite the business secretary being warned privately that it was an “urgent issue” www.thetimes.com/business-mon...
thetimes.com
AstraZeneca’s £450m plant hits setback caused by Whitehall delays
Government delays threaten AstraZeneca’s vaccine facility in Speke, jeopardising a key investment and raising questions about the UK’s commitment to life sciences
000
Alex Ralph @alexralph.bsky.social · 03/01/2025
The administrators of Safe Hands Plans, the pre-paid funerals company whose collapse has left 46,000 customers with a combined £60 million shortfall, have succeeded in appointing liquidators to a Cayman Islands company where customer money was funnelled www.thetimes.com/article/346c...
thetimes.com
Safe Hands administrators appoint Cayman Islands liquidator
FRP says licensed insolvency practitioners have taken control of company where customers’ money was funnelled
011
Alex Ralph @alexralph.bsky.social · 27/12/2024
AstraZeneca, Britain’s most valuable public company, has made about £45 million in payments to doctors and healthcare organisations in Russia since the war against Ukraine, despite the UK’s growing involvement www.thetimes.com/article/ac81...
thetimes.com
AstraZeneca paid £45m to doctors in Russia since war began
Analysis of data by The Times shows that the British pharmaceutical company has made the payments over two years at a time when other multinationals have pulled out of Russia
020